Contact
Please use this form to send email to PR contact of this press release:
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
TO:
Please use this form to send email to PR contact of this press release:
OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity
TO: